Literature DB >> 32564992

Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States.

R Chris Rathbun1, Spencer H Durham2, Kevin C Farmer3, Autumn D Zuckerman4, Melissa E Badowski5.   

Abstract

INTRODUCTION: Human immunodeficiency virus (HIV) is an important educational topic for student pharmacists given extended patient life expectancy and expanding pharmacist roles in HIV treatment and prevention. Data are lacking in regard to curricular content and type of training received by faculty to provide didactic and experiential HIV training.
METHODS: A cross-sectional, population-based survey of United States (US) pharmacy schools was conducted using a 15-item questionnaire. HIV content experts were surveyed at 135 four-year, accredited programs.
RESULTS: Thirty-seven responses were received from schools in the Midwestern (34%), Northeastern (26%), Southern (26%), and Western (14%) regions. Time devoted to didactic HIV education ranged from 0.5 to 60 hours. The majority of respondents (78%, n = 29) reported 10 or fewer hours of HIV-related content, with 41% (n = 15) reporting five or less hours of content. Experiential practice sites for HIV training were variable, with a majority (80%) including an outpatient infectious diseases/HIV clinic. Eighty percent of respondents also reported students receiving fewer than 25 encounters with people living with HIV (PLWH) throughout their entire experiential training. Over half (54%) of respondents reported that the primary HIV instructor devoted four hours per week or less to HIV care.
CONCLUSIONS: Diversity in the amount of time devoted to HIV didactic education existed among reporting US pharmacy schools. Few schools have dedicated faculty spending a substantial amount of time in direct care of PLWH. Minimum standards for HIV education in schools of pharmacy should be established.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Curriculum; HIV; Needs assessment; Pharmacy education; Teaching

Year:  2020        PMID: 32564992     DOI: 10.1016/j.cptl.2020.04.007

Source DB:  PubMed          Journal:  Curr Pharm Teach Learn        ISSN: 1877-1297


  2 in total

Review 1.  Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.

Authors:  Alice Zhao; Derek T Dangerfield; Amy Nunn; Rupa Patel; Jason E Farley; Chinenye C Ugoji; Lorraine T Dean
Journal:  AIDS Behav       Date:  2021-10-20

2.  Leveraging Expertise from Community Resources to Improve the Role of the Pharmacist in HIV Testing and Counseling.

Authors:  Edgar S Diaz-Cruz; Sara Thompson; Mary Hawkins; Riguin Zengotita-Borges; Kathryn Jefferson
Journal:  Innov Pharm       Date:  2021-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.